Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > What an idiot.

<< Previous

Bullboard Posts

Next >>

Comment by whisky11on Apr 02, 2021 11:47am

122 Views

Post# 32932030

RE:What an idiot.

losingmyshirt

whisky11: you are an idiot. He could say that he couldn't find the video and then case closed.
Being fair and honest and admit mistakes speaks volume about maverics2020 ,quite opposite about you, you idiot.

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs